A groundbreaking vision-restoration therapy based on Nobel Prize-winning optogenetics research has shown promising results in patients suffering from retinitis pigmentosa, a severe degenerative eye disease.
Researchers reported that several participants regained the ability to detect objects, identify locations, and interact with their surroundings after receiving the treatment.
The innovative approach combines gene therapy with specialized visual devices that convert information into light signals for remaining retinal cells. Scientists believe this breakthrough could open a new chapter in the treatment of blindness and severe vision loss.
About the Author
